Kate McKinley's most recent trade in Rani Therapeutics Holdings Inc - Ordinary Shares Class A was a trade of 120,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 13 Dec 2024 | 17,960 | 17,960 | - | 1.7 | 29,993 | Class A Common Stock |
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 323,500 | 323,500 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | McKinley Kate | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 250,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Kate McKinley | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |